See Recent Shionogi-Sponsored Congress Presentations
Congresses
As part of our commitment to addressing unmet medical needs, Shionogi continues to investigate approved products and pipeline compounds. Shionogi presents its research at major congress events globally.
The content contained herein is for your information only. No reproduction, alteration, or distribution of this information is permitted. Information about investigational compounds or investigational uses of products does not imply FDA approval of these compounds or uses, nor does it establish the safety or efficacy of these compounds or uses. There is no guarantee that the investigational compounds or investigational uses will receive FDA approval. Shionogi does not recommend or suggest use of its products in a manner inconsistent with FDA-approved labeling.
Select a congress event or filter to view available congress presentations.
You Are Viewing Presentations
Cefiderocol use in treating patients with confirmed Stenotrophomonas maltophilia infections in US Hospitals during January 2020 - June 2022
Cefiderocol use in treating patients with confirmed Stenotrophomonas maltophilia infections in US Hospitals during January 2020 - June 2022
Combined results of the phase 2a/2b/3 randomized controlled trials of ensitrelvir for the treatment of COVID-19 infection
Combined results of the phase 2a/2b/3 randomized controlled trials of ensitrelvir for the treatment of COVID-19 infection
Comparative activity of cefiderocol on bloodstream infection isolates from US Hospital ICU patients
Comparative activity of cefiderocol on bloodstream infection isolates from US Hospital ICU patients
Correlation analysis of cefiderocol in vitro activity and in vivo efficacy against Acinetobacter baumannii strains with difficult-to-read MIC endpoints
Correlation analysis of cefiderocol in vitro activity and in vivo efficacy against Acinetobacter baumannii strains with difficult-to-read MIC endpoints
Determining effect of media and disk source on reproducibility and relationship between broth microdilution and disk diffusion testing of cefiderocol
Determining effect of media and disk source on reproducibility and relationship between broth microdilution and disk diffusion testing of cefiderocol
Developing SARS-CoV-2 viral dynamic model in patients with COVID-19 based on amount of viral RNA and viral titer
Developing SARS-CoV-2 viral dynamic model in patients with COVID-19 based on amount of viral RNA and viral titer
You Are Viewing Congress Locations
ESCMID 2025
CROI 2025
SCCM 2025
IDWeek 2024
NACFC 2024
IAS 2024
ESCMID 2024
SCCM 2024
IDWeek 2023
CHEST 2023
ESWI 2023
ISSX 2023
PAGE 2023
